SEC Form 4 · accession 0001144204-17-010485
HUMANIGEN, INC · HGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Morgan Lam
Officer — Chief Scientific Officer
Period of report
Feb 21, 2017
Accepted (ET)
Feb 22, 2017 · 9:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293310
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.92 | Feb 21, 2017 | A | 100,000 | A | — | Feb 20, 2027 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The options vest and become exercisable in 12 equal quarterly installments beginning on April 1, 2017.